10 hours agoTyvid's skin - attached vaccine is created
Periskopi(5 years ago)
(5 years ago)British scientists are developing the world's first coronary vaccine to stick to the skin and can be used as an alternative to people who fear needles. The silicon device releases small microns, each thinr than a hair, to break the skin barrier, and to monitor its efficiency [...]
British scientists are developing the world's first coronary vaccine to stick to the skin and can be used as an alternative to people who fear needles.
The silicon device releases small micronellas, each less than a hair, to break the skin barrier and to monitor its efficiency by measuring the body's immune response. According to Swiss University researchers, the patch is designed to allow patients to manage the vaccine and then monitor their body's response to it.
The glueer can mass a patient's inflammatory response to the vaccine by monitoring biomarketers in leather while all are held in their arm with tape or belt. They hope that this real-time measurement of the vaccine's effectiveness will help speed up the search for future COVID-19 explosions. The equipment will be easily distributed and will be produced at low cost, the team added, with the aim of expanding the model to adapt vaccines to other diseases in the future.
A prototype will take place before the end of March, researchers have said, with the goal of presenting it for clinical trials and later becoming available commercially within the next three years. According to project leader Sanjiv Sharma, the ability to measure vaccine efficiency quickly will address an incomplete clinical need and provide an innovative approach to developing vaccines.
This low-cost vaccine management device will ensure a safe return to work and management of the follow-up waves of the Covid-19 blast. Beyond pandemic, the field of this work could be expanded to be applied to other infectious diseases, as the nature of the platform allows for rapid adaptation.
